Uxin Competitors

Uxin (NASDAQ:UXIN) and Radware (NASDAQ:RDWR) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Insider and Institutional Ownership

70.5% of Radware shares are held by institutional investors. 21.6% of Radware shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Uxin and Radware's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations for Uxin and Radware, as reported by MarketBeat.com.

Radware has a consensus target price of $30.00, indicating a potential upside of 4.02%. Given Radware's higher probable upside, analysts plainly believe Radware is more favorable than Uxin.

Risk & Volatility

Uxin has a beta of -0.28, suggesting that its share price is 128% less volatile than the S&P 500. Comparatively, Radware has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.

Earnings & Valuation

This table compares Uxin and Radware's revenue, earnings per share and valuation.

Radware has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than Radware, indicating that it is currently the more affordable of the two stocks.

Summary

Radware beats Uxin on 13 of the 13 factors compared between the two stocks.

Uxin (NASDAQ:UXIN) and Tabula Rasa HealthCare (NASDAQ:TRHC) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Profitability

This table compares Uxin and Tabula Rasa HealthCare's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations for Uxin and Tabula Rasa HealthCare, as reported by MarketBeat.com.

Tabula Rasa HealthCare has a consensus target price of $52.20, indicating a potential upside of 19.37%. Given Tabula Rasa HealthCare's higher probable upside, analysts plainly believe Tabula Rasa HealthCare is more favorable than Uxin.

Risk and Volatility

Uxin has a beta of -0.28, meaning that its stock price is 128% less volatile than the S&P 500. Comparatively, Tabula Rasa HealthCare has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.

Earnings & Valuation

This table compares Uxin and Tabula Rasa HealthCare's revenue, earnings per share and valuation.

Tabula Rasa HealthCare has higher revenue and earnings than Uxin. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Uxin, indicating that it is currently the more affordable of the two stocks.

Summary

Tabula Rasa HealthCare beats Uxin on 9 of the 11 factors compared between the two stocks.

Uxin (NASDAQ:UXIN) and i3 Verticals (NASDAQ:IIIV) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations for Uxin and i3 Verticals, as reported by MarketBeat.com.

i3 Verticals has a consensus target price of $37.25, indicating a potential upside of 12.00%. Given i3 Verticals' higher probable upside, analysts plainly believe i3 Verticals is more favorable than Uxin.

Earnings & Valuation

This table compares Uxin and i3 Verticals' revenue, earnings per share and valuation.

i3 Verticals has lower revenue, but higher earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than i3 Verticals, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Uxin and i3 Verticals' net margins, return on equity and return on assets.

Insider and Institutional Ownership

61.1% of i3 Verticals shares are held by institutional investors. 40.1% of i3 Verticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Uxin has a beta of -0.28, suggesting that its share price is 128% less volatile than the S&P 500. Comparatively, i3 Verticals has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500.

Summary

i3 Verticals beats Uxin on 12 of the 14 factors compared between the two stocks.

GreenSky (NASDAQ:GSKY) and Uxin (NASDAQ:UXIN) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Analyst Recommendations

This is a breakdown of recent ratings for GreenSky and Uxin, as reported by MarketBeat.

GreenSky currently has a consensus target price of $4.0938, suggesting a potential downside of 24.61%. Given GreenSky's higher probable upside, equities analysts clearly believe GreenSky is more favorable than Uxin.

Earnings and Valuation

This table compares GreenSky and Uxin's top-line revenue, earnings per share and valuation.

GreenSky has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than GreenSky, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares GreenSky and Uxin's net margins, return on equity and return on assets.

Insider & Institutional Ownership

35.5% of GreenSky shares are owned by institutional investors. 54.8% of GreenSky shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

GreenSky has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Comparatively, Uxin has a beta of -0.28, suggesting that its stock price is 128% less volatile than the S&P 500.

Summary

GreenSky beats Uxin on 11 of the 12 factors compared between the two stocks.

QuinStreet (NASDAQ:QNST) and Uxin (NASDAQ:UXIN) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Profitability

This table compares QuinStreet and Uxin's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares QuinStreet and Uxin's top-line revenue, earnings per share and valuation.

QuinStreet has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than QuinStreet, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

86.6% of QuinStreet shares are owned by institutional investors. 9.0% of QuinStreet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

QuinStreet has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, Uxin has a beta of -0.28, suggesting that its stock price is 128% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for QuinStreet and Uxin, as reported by MarketBeat.

QuinStreet currently has a consensus target price of $26.00, suggesting a potential upside of 32.52%. Given QuinStreet's higher probable upside, equities analysts clearly believe QuinStreet is more favorable than Uxin.

Summary

QuinStreet beats Uxin on 13 of the 13 factors compared between the two stocks.

Ideanomics (NASDAQ:IDEX) and Uxin (NASDAQ:UXIN) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Profitability

This table compares Ideanomics and Uxin's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Ideanomics and Uxin's top-line revenue, earnings per share and valuation.

Ideanomics has higher earnings, but lower revenue than Uxin.

Insider & Institutional Ownership

4.7% of Ideanomics shares are owned by institutional investors. 21.5% of Ideanomics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for Ideanomics and Uxin, as provided by MarketBeat.com.

Ideanomics presently has a consensus price target of $7.00, suggesting a potential upside of 197.87%. Given Ideanomics' higher probable upside, research analysts clearly believe Ideanomics is more favorable than Uxin.

Summary

Ideanomics beats Uxin on 6 of the 11 factors compared between the two stocks.